Unknown

Dataset Information

0

Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO.

ABSTRACT: BACKGROUND:Portal vein occlusion (PVO) is an established method to increase the volume of the future liver remnant (FLR). The main reasons for not proceeding to radical hepatectomy are lack of volume increase and tumor progression due to a wait-time interval of up to 8 weeks. The hypothesis was that the increase in FLR volume is not linear and is largest during the first weeks. METHODS:Patients with colorectal liver metastases (CRLM) and standardized future liver remnant (sFLR)

SUBMITTER: Hasselgren K 

PROVIDER: S-EPMC6414468 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO.

Hasselgren Kristina K   Sandström Per P   Røsok Bård Ingvald BI   Sparrelid Ernesto E   Lindell Gert G   Larsen Peter Nørgaard PN   Larsson Anna Lindhoff AL   Schultz Nicolai A NA   Björnbeth Bjorn Atle BA   Isaksson Bengt B   Rizell Magnus M   Björnsson Bergthor B  

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20181121 3

<h4>Background</h4>Portal vein occlusion (PVO) is an established method to increase the volume of the future liver remnant (FLR). The main reasons for not proceeding to radical hepatectomy are lack of volume increase and tumor progression due to a wait-time interval of up to 8 weeks. The hypothesis was that the increase in FLR volume is not linear and is largest during the first weeks.<h4>Methods</h4>Patients with colorectal liver metastases (CRLM) and standardized future liver remnant (sFLR) <   ...[more]

Similar Datasets

Unknown Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy.
| S-EPMC9458562 | biostudies-literature
Unknown Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS.
| S-EPMC9324888 | biostudies-literature
Unknown Comparison of functional and volumetric increase of the future remnant liver and postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for staged hepatectomy (ALPPS).
| S-EPMC7210209 | biostudies-literature
Unknown Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant.
| S-EPMC9867667 | biostudies-literature
Unknown Multi-organ Radiomics-Based Prediction of Future Remnant Liver Hypertrophy Following Portal Vein Embolization.
| S-EPMC10625940 | biostudies-literature
Transcriptomics Liver expression data from 1 week old mouse portal tracts
2014-11-05 | GSE62991 | GEO
Unknown "Winning" with laparoscopic liver resection for colorectal cancer liver metastases (CRLM).
| S-EPMC11806150 | biostudies-literature
Unknown Predictive Factors for Hypertrophy of the Future Liver Remnant After Portal Vein Embolization: A Systematic Review.
| S-EPMC8382618 | biostudies-literature
Unknown Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant.
| S-EPMC11312699 | biostudies-literature
Transcriptomics Liver expression data from 1 week old mouse portal tracts
2014-11-05 | E-GEOD-62991 | biostudies-arrayexpress